High S100A4 expression associates with poor outcome in early-stage cancers24 and direct interaction between S100A4 and RAGE was recently shown to promote motility in colorectal cancer cells via ERK-dependent mechanism72,73, and prostate cancer cells via NF-κB-activated pathway40. This evidence concerns the gene S100A4 and prostate carcinoma.